Last update 01 Nov 2024

BMS-813160

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Mechanism
CCR2 antagonists(C-C chemokine receptor type 2 antagonists), CCR5 antagonists(C-C chemokine receptor type 5 antagonists)
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC25H40N8O2
InChIKeyCMVHFGNTABZQJU-HCXYKTFWSA-N
CAS Registry1286279-29-5

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
US
08 Aug 2017
Advanced Malignant Solid NeoplasmPhase 2
ES
08 Aug 2017
Diabetes Mellitus, Type 2Phase 2
CA
18 Mar 2013
Diabetes Mellitus, Type 2Phase 2
FR
18 Mar 2013
Diabetes Mellitus, Type 2Phase 2
US
18 Mar 2013
Diabetes Mellitus, Type 2Phase 2
DK
18 Mar 2013
Diabetic NephropathiesPhase 2
US
18 Mar 2013
Diabetic NephropathiesPhase 2
FR
18 Mar 2013
Diabetic NephropathiesPhase 2
DK
18 Mar 2013
Diabetic NephropathiesPhase 2
CA
18 Mar 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
13
(bmamdawnfr) = qujhrzhtch zotkeadzdb (agwjftfkfz )
Positive
24 Jan 2023
Phase 1/2
40
(Part A - Experimental Dose Level 0)
fwjhljbmdn(dddazzrngp) = hwdbendizp yluegbbunp (rjlyafwsjw, ynectyyxxq - vdwjjsoier)
-
30 Nov 2022
Peripheral blood+nab-paclitaxel+Gemcitabine
(Part A - Control (Chemotherapy Only))
mtuvxnyoer(cbemokgbmd) = xcmjptaixc bygqiueaff (dkcmbgscew, keryfnrexw - xwtzseqtnb)
Phase 2
319
(BMS-813160 150 mg QD)
mzqcurwxex(rdljmbilij) = poiajtvhyy mgpxaleusj (afjhnykuja, liqdfxikqs - jaagprdhio)
-
25 Jun 2019
(BMS-813160 300 mg BID)
mzqcurwxex(rdljmbilij) = ztjfsxnvga mgpxaleusj (afjhnykuja, oeixeptyvj - rkulruioqw)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free